Communiqués Eurofins Scientific SE

Actions

ERF

FR0014000MR3

Recherche biotechnologique et médicale

PEA

Temps réel Euronext Paris 17:19:08 04/09/2026			Varia. 5j.	Varia. 1 janv.
72,86 ^EUR	-0,82 %		+0,75 %	+16,83 %

26/08	L'Europe termine en hausse... et les regards se tournent vers l'Amérique
24/08	Avis d'analystes du jour : avis positifs sur ArcelorMittal, Eurofins et Unibail

Communiqués

14:41	Eurofins Scientific: Director/PDMR Shareholding	BU
10:40	Eurofins Scientific: Director/PDMR Shareholding	BU
03/09	Eurofins Scientific: Director/PDMR Shareholding	BU
01/09	Eurofins Scientific SE: Director/PDMR Shareholding	BU
01/09	Eurofins Scientific SE: Director/PDMR Shareholding	BU
31/08	Eurofins Scientific SE: Weekly Report on Share Repurchases from 24th August to 28th August 2026	BU
31/08	Eurofins Scientific SE : Director/PDMR Shareholding	BU
27/08	Eurofins Scientific: Director/PDMR Shareholding	BU
24/08	Eurofins: Weekly Report on Share Repurchases From 17th August to 21st August 2026	BU
24/08	Eurofins Scientific SE: Director/PDMR Shareholding	BU
19/08	Eurofins Scientific: Director/PDMR Shareholding	BU
18/08	Eurofins Scientific SE: Weekly Report on Share Repurchases from 10th August to 14th August 2026	BU
14/08	Eurofins Scientific: Director/PDMR Shareholding	BU
13/08	Eurofins CDMO Alphora Expands Kilolab and High Potency Development and Manufacturing Capabilities	BU
12/08	Eurofins Scientific: Director/PDMR Shareholding	BU
10/08	Eurofins Scientific SE: Weekly Report on Share Repurchases from 03rd August to 07th August 2026	BU
07/08	Eurofins Scientific: Director/PDMR Shareholding	BU
04/08	Eurofins Scientific: Director/PDMR Shareholding	BU
03/08	Eurofins: Weekly Report on Share Repurchases From 27th July to 31st July 2026	BU
03/08	Eurofins Scientific SE: Director/PDMR Shareholding	BU
31/07	Eurofins Scientific: Director/PDMR Shareholding	BU
29/07	Eurofins Scientific: Director/PDMR Shareholding	BU
27/07	Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026	BU
24/07	Eurofins Scientific: Director/PDMR Shareholding	BU
23/07	Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth	BU